Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lorenzo Pradelli
   Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea
   Farmeconomia e percorsi terapeutici
   
   Lorenzo Pradelli, "Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea", Farmeconomia e percorsi terapeutici, 6(4), 2005, pp. 305-316
2. Laederach-Hofmann, K; Truniger, C; Mussgay, L; Jurgensen, R
   Sensory and affective components in the use of pain words in patients suffering from angina pectoris due to coronary artery disease or syndrome-x
   ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
   
   K. Laederach-Hofmann et al., "Sensory and affective components in the use of pain words in patients suffering from angina pectoris due to coronary artery disease or syndrome-x", Z KLIN P P, 30(3), 2001, pp. 182-188
3. Sun, SS; Huang, JL; Tsai, SC; Ho, YJ; Kao, CH
   The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT
   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
   
   S.S. Sun et al., "The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT", INT J CARDI, 17(4), 2001, pp. 271-278
4. Kingma, JG; Linderoth, B; Ardell, JL; Armour, JA; DeJongste, MJL; Foreman, RD
   Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia
   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
   
   J.G. Kingma et al., "Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia", AUTON NEURO, 91(1-2), 2001, pp. 47-54
5. Zamotrinsky, AV; Kondratiev, B; de Jong, JW
   Vagal neurostimulation in patients with coronary artery disease
   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
   
   A.V. Zamotrinsky et al., "Vagal neurostimulation in patients with coronary artery disease", AUTON NEURO, 88(1-2), 2001, pp. 109-116
6. Langevitz, P; Livneh, A; Neumann, L; Buskila, D; Shemer, J; Amolsky, D; Pras, M
   Prevalence of ischemic heart disease in patients with familial Mediterranean fever
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   P. Langevitz et al., "Prevalence of ischemic heart disease in patients with familial Mediterranean fever", ISR MED ASS, 3(1), 2001, pp. 9-12
7. Cavusoglu, Y; Gorenek, B; Alpsoy, S; Unalir, A; Ata, N; Timuralp, B
   Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   Y. Cavusoglu et al., "Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease", ISR MED ASS, 3(1), 2001, pp. 13-16
8. Magadle, R; Weiner, P; Sotzkover, A; Berar-Yanay, N
   C-reactive protein and vascular disease
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   R. Magadle et al., "C-reactive protein and vascular disease", ISR MED ASS, 3(1), 2001, pp. 50-52
9. Schillinger, M; Haumer, M; Schlerka, G; Mlekusch, W; Exner, M; Ahmadi, R; Minar, E
   Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation
   JOURNAL OF ENDOVASCULAR THERAPY
   
   M. Schillinger et al., "Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation", J ENDOVAS T, 8(5), 2001, pp. 477-483
10. Mariani, G; De Servi, S; Dellavalle, A; Repetto, S; Chierchia, S; D'Urbano, M; Repetto, A; Klersy, C
    Complete or incomplete percutaneous coronary revascularization in patientswith unstable angina in stent era: Are early and one-year results different?
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    G. Mariani et al., "Complete or incomplete percutaneous coronary revascularization in patientswith unstable angina in stent era: Are early and one-year results different?", CATHET C IN, 54(4), 2001, pp. 448-453
11. Lincoff, AM
    Anticoagulant and antiplatelet drugs
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    A.M. Lincoff, "Anticoagulant and antiplatelet drugs", CATHET C IN, 54(4), 2001, pp. 514-520
12. Stefanadis, C; Toutouzas, K; Tsiamis, E; Vavuranakis, M; Kallikazaros, I; Toutouzas, P
    Thermography of human arterial system by means of new thermography catheters
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    C. Stefanadis et al., "Thermography of human arterial system by means of new thermography catheters", CATHET C IN, 54(1), 2001, pp. 51-58
13. Rodes, J; Tanguay, JF; Bertrand, OF; Malekianpour, M; Lesperance, J; Cote, G; Theroux, P
    Late (> 48 hr) myocardial infarction after PTCA: Clinical and angiographiccharacteristics of infarction related or not to the angioplasty site
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    J. Rodes et al., "Late (> 48 hr) myocardial infarction after PTCA: Clinical and angiographiccharacteristics of infarction related or not to the angioplasty site", CATHET C IN, 53(2), 2001, pp. 155-162
14. Saadeddin, SM; Habbab, MA; Sobki, SH; Ferns, GA
    Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    S.M. Saadeddin et al., "Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins", CATHET C IN, 53(2), 2001, pp. 188-192
15. Laham, RJ; Baim, DS
    Combined percutaneous biosense-guided laser myocardial revascularization and coronary intervention
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    R.J. Laham e D.S. Baim, "Combined percutaneous biosense-guided laser myocardial revascularization and coronary intervention", CATHET C IN, 53(2), 2001, pp. 235-240
16. Turi, ZG
    Guided laser myocardial revascularization with coronary angioplasty: The emperor shops for new clothes
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    Z.G. Turi, "Guided laser myocardial revascularization with coronary angioplasty: The emperor shops for new clothes", CATHET C IN, 53(2), 2001, pp. 241-242
17. Gibson, CM; Kirtane, AJ; Murphy, SA; Marble, SJ; de Lemos, JA; Antman, EM; Braunwald, E
    Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    C.M. Gibson et al., "Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction", CATHET C IN, 53(1), 2001, pp. 6-11
18. Muramatsu, T; Tsukahara, R; Ho, M; Ito, Y; Ishimori, H; Saiki, N
    Intravascular ultrasound findings in patients with abnormal coronary flow reserve after stenting
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    T. Muramatsu et al., "Intravascular ultrasound findings in patients with abnormal coronary flow reserve after stenting", CATHET C IN, 52(4), 2001, pp. 420-424
19. Bittl, JA
    Editorial comment - From confusion to clarity: Direct thrombin inhibitors for patients with heparin-induced thrombocytopenia
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    J.A. Bittl, "Editorial comment - From confusion to clarity: Direct thrombin inhibitors for patients with heparin-induced thrombocytopenia", CATHET C IN, 52(4), 2001, pp. 473-475
20. Stanley, WC
    Changes in cardiac metabolism: a critical step from stable angina to ischaemic cardiomyopathy
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    W.C. Stanley, "Changes in cardiac metabolism: a critical step from stable angina to ischaemic cardiomyopathy", EUR H J SUP, 3(O), 2001, pp. O2-O7
21. Klein, W
    Treatment patterns in stable angina: objectives and reality
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    W. Klein, "Treatment patterns in stable angina: objectives and reality", EUR H J SUP, 3(O), 2001, pp. O8-O11
22. Marzilli, M
    Trimetazidine: a metabolic agent for the treatment of stable angina
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    M. Marzilli, "Trimetazidine: a metabolic agent for the treatment of stable angina", EUR H J SUP, 3(O), 2001, pp. O12-O15
23. Danchin, N
    Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    N. Danchin, "Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention", EUR H J SUP, 3(O), 2001, pp. O21-O25
24. Antman, EM; Corbalan, R; Huber, K; Jaffe, AS
    Issues in early risk stratification for UA/NSTEMI
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    E.M. Antman et al., "Issues in early risk stratification for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J6-J14
25. Alpert, JS; Budaj, AJ; Gurfinkel, EP; Henry, TD
    Issues in antithrombin therapy for UA/NSTEMI
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.S. Alpert et al., "Issues in antithrombin therapy for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J15-J23
26. Chatterjee, K; Col, J; Dalby, AJ; Gulba, D
    Issues in antiplatelet therapy for UA/NSTEMI
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    K. Chatterjee et al., "Issues in antiplatelet therapy for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J24-J31
27. Hod, HH; Kleiman, NS; Sequeira, RF; Voipio-Pulkki, LM
    Issues in cardiac intervention for UA/NSTEMI
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    H.H. Hod et al., "Issues in cardiac intervention for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J32-J39
28. Bernink, PJLM; Flather, M; Hochman, JS; Rogers, WJ
    Issues in discharge therapy after hospitalization for UA/NSTEMI
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    P.J.L.M. Bernink et al., "Issues in discharge therapy after hospitalization for UA/NSTEMI", EUR H J SUP, 3(J), 2001, pp. J40-J46
29. Bentzon, JF; Falk, E
    Coronary plaques calling for action - why, where and how many?
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.F. Bentzon e E. Falk, "Coronary plaques calling for action - why, where and how many?", EUR H J SUP, 3(I), 2001, pp. I3-I9
30. Kaski, JC; Zouridakis, EG
    Inflammation, infection and acute coronary plaque events
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.C. Kaski e E.G. Zouridakis, "Inflammation, infection and acute coronary plaque events", EUR H J SUP, 3(I), 2001, pp. I10-I15
31. Badimon, L; Vilahur, G; Sanchez, S; Duran, X
    Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    L. Badimon et al., "Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches", EUR H J SUP, 3(I), 2001, pp. I16-I22
32. Cruz-Fernandez, JM
    Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.M. Cruz-Fernandez, "Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors", EUR H J SUP, 3(I), 2001, pp. I23-I30
33. Shaw, LJ; Berman, DS; Miller, DD
    Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    L.J. Shaw et al., "Cost-effectiveness of myocardial perfusion imaging in the evaluation of patients with known or suspected coronary artery disease", EUR H J SUP, 3(F), 2001, pp. F15-F18
34. Ferrari, R
    Pathophysiological vs biochemical ischaemia: a key to transition from reversible to irreversible damage
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    R. Ferrari, "Pathophysiological vs biochemical ischaemia: a key to transition from reversible to irreversible damage", EUR H J SUP, 3(C), 2001, pp. C2-C10
35. Lopez-Sendon, J
    Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J. Lopez-Sendon, "Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit", EUR H J SUP, 3(C), 2001, pp. C55-C61
36. Hamm, CW
    GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    C.W. Hamm, "GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection", EUR H J SUP, 3(A), 2001, pp. A14-A20
37. Woollard, M; Smith, A; Elwood, P
    Pre-hospital aspirin for suspected myocardial infarction and acute coronary syndromes: A headache for paramedics?
    EMERGENCY MEDICINE JOURNAL
    
    M. Woollard et al., "Pre-hospital aspirin for suspected myocardial infarction and acute coronary syndromes: A headache for paramedics?", EMERG MED J, 18(6), 2001, pp. 478-481
38. Huggon, AM; Chambers, J; Nayeem, N; Tutt, P; Crook, M; Swaminathan, S
    Biochemical markers in the management of suspected acute myocardial infarction in the emergency department
    EMERGENCY MEDICINE JOURNAL
    
    A.M. Huggon et al., "Biochemical markers in the management of suspected acute myocardial infarction in the emergency department", EMERG MED J, 18(1), 2001, pp. 15-19
39. Crossman, D
    Acute coronary syndromes
    CLINICAL MEDICINE
    
    D. Crossman, "Acute coronary syndromes", CLIN MED, 1(3), 2001, pp. 206-213
40. Kerner, T; Ahlers, O; Reschreiter, H; Buhrer, C; Mockel, M; Gerlach, H
    Adhesion molecules in different treatments of acute myocardial infarction
    CRITICAL CARE
    
    T. Kerner et al., "Adhesion molecules in different treatments of acute myocardial infarction", CRIT CARE, 5(3), 2001, pp. 145-150
41. Norris, R
    Redefining myocardial infarction - Reply
    HOSPITAL MEDICINE
    
    R. Norris, "Redefining myocardial infarction - Reply", HOSP MED, 62(8), 2001, pp. 510-510
42. Wood, DA; Fox, KF; Gibbs, SR
    Rapid cardiology - for chest pain, breathlessness and palpitations
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    D.A. Wood et al., "Rapid cardiology - for chest pain, breathlessness and palpitations", QJM-MON J A, 94(4), 2001, pp. 177-178
43. De Lorenzo, F; Noorani, A; Kakkar, VV
    Current trends in the management of thromboembolic events
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    F. De Lorenzo et al., "Current trends in the management of thromboembolic events", QJM-MON J A, 94(4), 2001, pp. 179-185
44. Fitzpatrick, MA
    Guidelines for acute coronary syndromes: translating the evidence to best practice
    INTERNAL MEDICINE JOURNAL
    
    M.A. Fitzpatrick, "Guidelines for acute coronary syndromes: translating the evidence to best practice", INTERN M J, 31(2), 2001, pp. 69-72
45. Aroney, C; Boyden, AN; Jelinek, MV; Thompson, P; Tonkin, AM; White, H
    Current guidelines for the management of unstable angina: a new diagnosticand management paradigm
    INTERNAL MEDICINE JOURNAL
    
    C. Aroney et al., "Current guidelines for the management of unstable angina: a new diagnosticand management paradigm", INTERN M J, 31(2), 2001, pp. 104-111
46. Weber, C; Steiner, P; Baldus, S; Pourtehrani, PY; Adam, G
    MRI first-pass myocardial perfusion in patients undergoing percutaneous loser revascularization
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    C. Weber et al., "MRI first-pass myocardial perfusion in patients undergoing percutaneous loser revascularization", ROFO-F RONT, 173(4), 2001, pp. 329-335
47. Mazzone, A; Cusa, C; Mazzucchelli, I; Vezzoli, M; Ottini, E; Ghio, S; Tossini, G; Pacifici, R; Zuccaro, P
    Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    A. Mazzone et al., "Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules", CLIN CH L M, 39(9), 2001, pp. 822-826
48. de Marchi, SF; Schwerzmann, M; Billinger, M; Windecker, S; Meier, B; Seiler, C
    Sympathetic stimulation using the cold pressor test increases coronary collateral flow
    SWISS MEDICAL WEEKLY
    
    S.F. de Marchi et al., "Sympathetic stimulation using the cold pressor test increases coronary collateral flow", SWISS MED W, 131(23-24), 2001, pp. 351-356
49. Lindahl, B
    Detection of myocardial damage - are the troponins the ultimate solution?
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    B. Lindahl, "Detection of myocardial damage - are the troponins the ultimate solution?", SC CARDIOVA, 35(4), 2001, pp. 229-232
50. Graven, T; Kruger, O; Bronstad, G
    Epidemiological consequences of introducing new biochemical markers for detection of acute myocardial infarction
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    T. Graven et al., "Epidemiological consequences of introducing new biochemical markers for detection of acute myocardial infarction", SC CARDIOVA, 35(4), 2001, pp. 233-237
51. Bengtsson, I; Hagman, M; Wedel, H
    Age and angina as predictors of quality of life after myocardial infarction - A prospective comparative study
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    I. Bengtsson et al., "Age and angina as predictors of quality of life after myocardial infarction - A prospective comparative study", SC CARDIOVA, 35(4), 2001, pp. 252-258
52. Bjessmo, S; Ivert, T; Egberg, N
    Coagulation system activity before coronary artery bypass surgery for unstable angina
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    S. Bjessmo et al., "Coagulation system activity before coronary artery bypass surgery for unstable angina", SC CARDIOVA, 35(4), 2001, pp. 280-284
53. Thuesen, L
    Myocardial laser revascularization - The end of a new therapy?
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    L. Thuesen, "Myocardial laser revascularization - The end of a new therapy?", SC CARDIOVA, 35(1), 2001, pp. 6-7
54. Aaberge, L; Rootwelt, K; Smith, HJ; Nordstrand, K; Forfang, K
    Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    L. Aaberge et al., "Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods", SC CARDIOVA, 35(1), 2001, pp. 8-13
55. Wiseth, R; Forfang, K; Ilebekk, A; Myhre, KI; Nordrehaug, JE; Sorlie, D
    Myocardial laser revascularization in the year 2000 as seen by a Norwegianspecialist panel - The process of evaluating and implementing new methods in clinical practice
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    R. Wiseth et al., "Myocardial laser revascularization in the year 2000 as seen by a Norwegianspecialist panel - The process of evaluating and implementing new methods in clinical practice", SC CARDIOVA, 35(1), 2001, pp. 14-18
56. Tjomsland, O; Aaberge, L; Almdahl, SM; Moelstad, P; Rootwelt, K; Nordstrand, K; Saatvedt, K
    Cardiac enzymes after transmyocardial laser treatment with CO2 laser
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    O. Tjomsland et al., "Cardiac enzymes after transmyocardial laser treatment with CO2 laser", SC CARDIOVA, 35(1), 2001, pp. 19-24
57. Ecochard, R; Colin, C; Rabilloud, M; de Gevigney, G; Cao, D; Ducreux, C; Delahaye, F
    Indicators of myocardial dysfunction and quality of life, one year after acute infarction
    EUROPEAN JOURNAL OF HEART FAILURE
    
    R. Ecochard et al., "Indicators of myocardial dysfunction and quality of life, one year after acute infarction", EUR J HE FA, 3(5), 2001, pp. 561-568
58. Leopold, C; Schandry, R
    The heartbeat-evoked brain potential in patients suffering from diabetic neuropathy and in healthy control persons
    CLINICAL NEUROPHYSIOLOGY
    
    C. Leopold e R. Schandry, "The heartbeat-evoked brain potential in patients suffering from diabetic neuropathy and in healthy control persons", CLIN NEU, 112(4), 2001, pp. 674-682
59. Kesmarky, G; Toth, K; Vajda, G; Habon, L; Halmosi, R; Roth, E
    Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    
    G. Kesmarky et al., "Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty", CL HEMORH M, 24(1), 2001, pp. 33-41
60. Toss, H; Wallentin, L; Siegbahn, A
    Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease
    FIBRINOLYSIS & PROTEOLYSIS
    
    H. Toss et al., "Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease", FIBRINOL PR, 15(1), 2001, pp. 26-31
61. Jackson, G
    Combination therapy in angina: A review of combined haemodynamic treatmentand the role for combined haemodynamic and cardiac metabolic agents
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. Jackson, "Combination therapy in angina: A review of combined haemodynamic treatmentand the role for combined haemodynamic and cardiac metabolic agents", INT J CL PR, 55(4), 2001, pp. 256-261
62. Ramsay, JMC; McDermott, MR; Bray, C
    Components of the anger-hostility complex and symptom reporting in patients with coronary artery disease: A multi-measure study
    JOURNAL OF HEALTH PSYCHOLOGY
    
    J.M.C. Ramsay et al., "Components of the anger-hostility complex and symptom reporting in patients with coronary artery disease: A multi-measure study", J HEAL PSYC, 6(6), 2001, pp. 713-729
63. Furze, G; Lewin, RJP; Roebuck, A; Thompson, DR; Bull, P
    Attributions and misconceptions in angina: An exploratory study
    JOURNAL OF HEALTH PSYCHOLOGY
    
    G. Furze et al., "Attributions and misconceptions in angina: An exploratory study", J HEAL PSYC, 6(5), 2001, pp. 501-510
64. Garlichs, CD; Eskafi, S; Raaz, D; Schmidt, A; Ludwig, J; Herrmann, M; Klinghammer, L; Daniel, WG; Schmeisser, A
    Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
    HEART
    
    C.D. Garlichs et al., "Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets", HEART, 86(6), 2001, pp. 649-655
65. Lampe, FC; Morris, RW; Whincup, PH; Walker, M; Ebrahim, S; Shaper, AG
    Is the prevalence of coronary heart disease falling in British men?
    HEART
    
    F.C. Lampe et al., "Is the prevalence of coronary heart disease falling in British men?", HEART, 86(5), 2001, pp. 499-505
66. Cobbe, SM; Campbell, RWF; Camm, AJ; Nathan, AW; Rowland, E; Bloch-Thomsen, PE; Moller, M; Jordaens, L
    Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia
    HEART
    
    S.M. Cobbe et al., "Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia", HEART, 86(5), 2001, pp. 522-526
67. Herlitz, J; Karlson, BW; Sjolin, M; Lindqvist, J
    Ten year mortality in subsets of patients with an acute coronary syndrome
    HEART
    
    J. Herlitz et al., "Ten year mortality in subsets of patients with an acute coronary syndrome", HEART, 86(4), 2001, pp. 391-396
68. Sadamatsu, K; Shimokawa, H; Tashiro, H; Yamamoto, K
    Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease
    HEART
    
    K. Sadamatsu et al., "Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease", HEART, 86(4), 2001, pp. 457-458
69. Tousoulis, D; Davies, GJ; Tentolouris, C; Goumas, G; Stefanadis, C; Toutouzas, P
    Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque
    HEART
    
    D. Tousoulis et al., "Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque", HEART, 86(3), 2001, pp. 296-301
70. Teragawa, H; Kato, M; Yamagata, T; Matsuura, H; Kajiyama, G
    Magnesium causes nitric oxide independent coronary artery vasodilation in humans
    HEART
    
    H. Teragawa et al., "Magnesium causes nitric oxide independent coronary artery vasodilation in humans", HEART, 86(2), 2001, pp. 212-216
71. Treasure, T
    Living with a univentricular heart
    HEART
    
    T. Treasure, "Living with a univentricular heart", HEART, 86(1), 2001, pp. 5-6
72. Mulvihill, NT; Foley, JB; Murphy, RT; Curtin, R; Crean, PA; Walsh, M
    Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules
    HEART
    
    N.T. Mulvihill et al., "Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules", HEART, 85(6), 2001, pp. 623-627
73. Bowling, A; Bond, M; McKee, D; McClay, M; Banning, AP; Dudley, N; Elder, A; Martin, A; Blackman, I
    Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications
    HEART
    
    A. Bowling et al., "Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications", HEART, 85(6), 2001, pp. 680-686
74. Mazzone, A; De Servi, S; Mazzucchelli, I; Bossi, I; Ottini, E; Vezzoli, M; Meloni, F; Lotzinker, M; Mariani, G
    Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T
    HEART
    
    A. Mazzone et al., "Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T", HEART, 85(5), 2001, pp. 571-575
75. Al-Obaidi, MK; Stubbs, PJ; Amersey, R; Noble, MIM
    Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes
    HEART
    
    M.K. Al-Obaidi et al., "Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes", HEART, 85(4), 2001, pp. 380-384
76. 
    Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation
    HEART
    
    HEART, 85(2), 2001, pp. 133-142
77. Pagano, D; Fath-Ordoubadi, F; Beatt, KJ; Townend, JN; Bonser, RS; Camici, PG
    Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium
    HEART
    
    D. Pagano et al., "Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium", HEART, 85(2), 2001, pp. 208-212
78. Steinmetzer, T; Hauptmann, J; Sturzebecher, J
    Advances in the development of thrombin inhibitors
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    T. Steinmetzer et al., "Advances in the development of thrombin inhibitors", EXPERT OP I, 10(5), 2001, pp. 845-864
79. Katsouras, CS; Karabina, SA; Tambaki, AP; Goudevenos, JA; Michalis, LK; Tsironis, LD; Stroumbis, CS; Elisaf, MS; Sideris, DA; Tselepis, AD
    Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease
    JOURNAL OF CARDIOVASCULAR RISK
    
    C.S. Katsouras et al., "Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease", J CARD RISK, 8(5), 2001, pp. 311-317
80. Schisterman, EF; Faraggi, D; Browne, R; Freudenheim, J; Dorn, J; Muti, P; Armstrong, D; Reiser, B; Trevisan, M
    TBARS and cardiovascular disease in a population-based sample
    JOURNAL OF CARDIOVASCULAR RISK
    
    E.F. Schisterman et al., "TBARS and cardiovascular disease in a population-based sample", J CARD RISK, 8(4), 2001, pp. 219-225
81. Cupples, ME; Dempster, M
    Improving quality of life for patients with angina pectoris - A team approach to disease management
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    M.E. Cupples e M. Dempster, "Improving quality of life for patients with angina pectoris - A team approach to disease management", DIS MANAG H, 9(9), 2001, pp. 473-481
82. Visseren, FLJ; Bouter, PK; van Loon, BJP; Erkelens, WD
    Treatment of dyslipidaemia with fluvastatin in patients with type 2 diabetes mellitus - Effects on lipids, mental state and fibrinolysis
    CLINICAL DRUG INVESTIGATION
    
    F.L.J. Visseren et al., "Treatment of dyslipidaemia with fluvastatin in patients with type 2 diabetes mellitus - Effects on lipids, mental state and fibrinolysis", CLIN DRUG I, 21(10), 2001, pp. 671-678
83. Staniforth, AD
    Contemporary management of chronic stable angina
    DRUGS & AGING
    
    A.D. Staniforth, "Contemporary management of chronic stable angina", DRUG AGING, 18(2), 2001, pp. 109-121
84. Bortolotti, M; Pandolfo, N; Miglioli, M
    Abnormal esophagocardiac reflex in patients with non-cardiac chest pain
    DISEASES OF THE ESOPHAGUS
    
    M. Bortolotti et al., "Abnormal esophagocardiac reflex in patients with non-cardiac chest pain", DIS ESOPHAG, 14(1), 2001, pp. 57-59
85. Abraham, R; Karamanoukian, HL; Jajkowski, MR; D'Ancona, G; Salerno, TA; Bergsland, J
    Low ejection fraction is not a contraindication to off-pump coronary artery surgery
    HEART SURGERY FORUM
    
    R. Abraham et al., "Low ejection fraction is not a contraindication to off-pump coronary artery surgery", HEART SUR F, 4(2), 2001, pp. 141-146
86. Merz, CNB; Johnson, BJ; Kelsey, SF; Reis, SE; Lewis, JF; Reichek, N; Rogers, WJ; Pepine, CF; Shaw, LJ
    Diagnostic, prognostic, and cost assessment of coronary artery disease in women
    AMERICAN JOURNAL OF MANAGED CARE
    
    C.N.B. Merz et al., "Diagnostic, prognostic, and cost assessment of coronary artery disease in women", AM J M CARE, 7(10), 2001, pp. 959-965
87. Osada, M; Takeda, S; Ogawa, R; Komori, S; Tamura, K
    T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    M. Osada et al., "T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty", J INTERF CY, 21(4), 2001, pp. 219-221
88. Chi, LQ; Li, Y; Stehno-Bittel, L; Gao, JJ; Morrison, DC; Stechschulte, FJ; Dileepan, KN
    Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    L.Q. Chi et al., "Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha", J INTERF CY, 21(4), 2001, pp. 231-240
89. Brull, DJ; Montgomery, HE; Sanders, J; Dhamrait, S; Luong, L; Rumley, A; Lowe, GDO; Humphries, SE
    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma - Interleukin-6 levels after coronary artery bypasssurgery
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    D.J. Brull et al., "Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma - Interleukin-6 levels after coronary artery bypasssurgery", ART THROM V, 21(9), 2001, pp. 1458-1463
90. Lemieux, I; Pascot, A; Prud'homme, D; Almeras, N; Bogaty, P; Nadeau, A; Bergeron, J; Despres, JP
    Elevated C-reactive protein - Another component of the atherothrombotic profile of abdominal obesity
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    I. Lemieux et al., "Elevated C-reactive protein - Another component of the atherothrombotic profile of abdominal obesity", ART THROM V, 21(6), 2001, pp. 961-967
91. Oldgren, J; Linder, R; Grip, L; Siegbahn, A; Wallentin, L
    Coagulation activity and clinical outcome in unstable coronary artery disease
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    J. Oldgren et al., "Coagulation activity and clinical outcome in unstable coronary artery disease", ART THROM V, 21(6), 2001, pp. 1059-1064
92. Lowe, GDO; Yarnell, JWG; Rumley, A; Bainton, D; Sweetnam, PM
    C-Reactive protein, fibrin D-dimer, and incident ischemic heart disease inthe speedwell study - Are inflammation and fibrin turnover linked in pathogenesis?
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    G.D.O. Lowe et al., "C-Reactive protein, fibrin D-dimer, and incident ischemic heart disease inthe speedwell study - Are inflammation and fibrin turnover linked in pathogenesis?", ART THROM V, 21(4), 2001, pp. 603-610
93. Folsom, AR; Aleksik, N; Park, E; Salomaa, V; Juneja, H; Wu, KK
    Prospective study of fibrinolytic factors and incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    A.R. Folsom et al., "Prospective study of fibrinolytic factors and incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study", ART THROM V, 21(4), 2001, pp. 611-617
94. Tokunou, T; Ichiki, T; Takeda, K; Funakoshi, Y; Iino, N; Shimokawa, H; Egashira, K; Takeshita, A
    Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    T. Tokunou et al., "Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells", ART THROM V, 21(11), 2001, pp. 1759-1763
95. Haramaki, N; Ikeda, H; Takajo, Y; Katoh, A; Kanaya, S; Shintani, S; Haramaki, R; Murohara, T; Imaizumi, T
    Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    N. Haramaki et al., "Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione", ART THROM V, 21(11), 2001, pp. 1852-1856
96. Weiss, RA
    Another calcium paradox?
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    R.A. Weiss, "Another calcium paradox?", ART THROM V, 21(10), 2001, pp. 1561-1562
97. Barbaux, SC; Blankenberg, S; Rupprecht, HJ; Francomme, C; Bickel, C; Hafner, G; Nicaud, V; Meyer, J; Cambien, F; Tiret, L
    Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    S.C. Barbaux et al., "Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease", ART THROM V, 21(10), 2001, pp. 1668-1673
98. Koenig, W; Rothenbacher, D; Hoffmeister, A; Griesshammer, M; Brenner, H
    Plasma fibrin D-dimer levels and risk of stable coronary artery disease - Results of a large case-control study
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    W. Koenig et al., "Plasma fibrin D-dimer levels and risk of stable coronary artery disease - Results of a large case-control study", ART THROM V, 21(10), 2001, pp. 1701-1705
99. Collett, JP; Montalescot, G; Lesty, C; Soria, J; Mishal, Z; Thoms, D; Soria, C
    Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    J.P. Collett et al., "Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis", ART THROM V, 21(1), 2001, pp. 142-148
100. Roberts, HW; Mitnitsky, EF
     Cardiac risk stratification for postmyocardial infarction dental patients
     ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
     
     H.W. Roberts e E.F. Mitnitsky, "Cardiac risk stratification for postmyocardial infarction dental patients", ORAL SURG O, 91(6), 2001, pp. 676-681